Fortrea Holdings Inc. (FTRE)

Market Cap	462.66M
Revenue (ttm)	2.69B
Net Income (ttm)	-790.40M
Shares Out	90.54M
EPS (ttm)	-8.81
PE Ratio	n/a
Forward PE	9.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,398,539
Open	5.12
Previous Close	5.27
Day's Range	4.99 - 5.16
52-Week Range	3.97 - 28.41
Beta	1.76
Analysts	Hold
Price Target	16.00 (+213.11%)
Earnings Date	Aug 11, 2025

About FTRE

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I – IV clinical trial management, clinical phar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 16,120
• Stock Exchange: NASDAQ
• Ticker Symbol: FTRE
• Website: https://www.fortrea.com

Financial Performance

In 2024, Fortrea Holdings's revenue was $2.70 billion, a decrease of -5.14% compared to the previous year's $2.84 billion. Losses were -$328.50 million, 1203.6% more than in 2023.

Analyst Summary

According to 11 analysts, the average rating for FTRE stock is "Hold." The 12-month stock price target is $16.0, which is an increase of 213.11% from the latest price.

Price Target

$16.0

(213.11% upside)

Analyst Consensus: Hold